MYC and liver cancer: 3 months after HTVI, only sgKmt2c resulted in liver tumor formation with high penetrance (Figure 1—figure supplement 1B), suggesting that MLL3 likely acts as a tumor suppressor to constrain Myc-driven liver cancer.